Thrombospondin-4 expression is rapidly upregulated by cardiac overload

Biochemical and Biophysical Research Communications

Volumn 373, Issue 2, 2008, Pages 186-191

  Mustonen, Erja ^a   Aro, Jani ^a   Puhakka, Jutta ^a   Ilves, Mika ^a   Soini, Ylermi ^a   Leskinen, Hanna ^a   Ruskoaho, Heikki ^a   Rysä, Jaana ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Endothelial cells; Extracellular matrix; Gene expression; Heart failure; Hypertrophy; Myocardial infarction; Pressure overload; Remodeling; Thrombospondins

Indexed keywords

ANGIOTENSIN II; ARGIPRESSIN; THROMBOSPONDIN; THROMBOSPONDIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE INDUCTION; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UPREGULATION;

AGING; ANIMALS; BIOLOGICAL MARKERS; HEART; MALE; MYOCARDIAL INFARCTION; PRESSURE; RATS; RATS, INBRED STRAINS; THROMBOSPONDIN 1; THROMBOSPONDINS; TRANS-ACTIVATION (GENETICS); UP-REGULATION; VENTRICULAR REMODELING;

RATTUS;

EID: 46249116463     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.164     Document Type: Article

References (31)

1. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79 (1999) 215-262
2. Hoshijima M., and Chien K.R. Mixed signals in heart failure: cancer rules. J. Clin. Invest. 109 (2002) 849-855
3. Bornstein P., and Sage E.H. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol. 14 (2002) 608-616
4. Schellings M.W., Pinto Y.M., and Heymans S. Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc. Res. 64 (2004) 24-31
5. Adams J.C. Thrombospondins: multifunctional regulators of cell interactions. Annu. Rev. Cell Dev. Biol. 17 (2001) 25-51
6. Frangogiannis N.G., Ren G., Dewald O., Zymek P., Haudek S., Koerting A., Winkelmann K., Michael L.H., Lawler J., and Entman M.L. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 111 (2005) 2935-2942
7. Sezaki S., Hirohata S., Iwabu A., Nakamura K., Toeda K., Miyoshi T., Yamawaki H., Demircan K., Kusachi S., Shiratori Y., and Ninomiya Y. Thrombospondin-1 is induced in rat myocardial infarction and its induction is accelerated by ischemia/reperfusion. Exp. Biol. Med. (Maywood) 23 (2005) 621-630
8. Schroen B., Heymans S., Sharma U., Blankesteijn W.M., Pokharel S., Cleutjens J.P., Porter J.G., Evelo C.T., Duisters R., van Leeuwen R.E., Janssen B.J., Debets J.J., Smits J.F., Daemen M.J., Crijns H.J., Bornstein P., and Pinto Y.M. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ. Res. 95 (2004) 515-522
9. Blankesteijn W.M., Creemers E., Lutgens E., Cleutjens J.P., Daemen M.J., and Smits J.F. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol. Scand. 173 (2001) 75-82
10. Hankenson K.D., Hormuzdi S.G., Meganck J.A., and Bornstein P. Mice with a disruption of the thrombospondin 3 gene differ in geometric and biomechanical properties of bone and have accelerated development of the femoral head. Mol. Cell. Biol. 25 (2005) 5599-5606
11. Rysä J., Leskinen H., Ilves M., and Ruskoaho H. Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 45 (2005) 927-933
12. Magga J., Marttila M., Mäntymaa P., Vuolteenaho O., and Ruskoaho H. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology 134 (1994) 2505-2515
13. Romppanen H., Puhakka J., Foldes G., Szokodi I.I., Vuolteenaho O., Tokola H., Toth M., and Ruskoaho H. Endothelin-1-independent and angiotensin II-independent induction of adrenomedullin gene expression. Hypertension 37 (2001) 84-90
14. Foldes G., Suo M., Szokodi I., Lako-Futo Z., deChatel R., Vuolteenaho O., Huttunen P., Ruskoaho H., and Toth M. Factors derived from adrenals are required for activation of cardiac gene expression in angiotensin II-induced hypertension. Endocrinology 142 (2001) 4256-4263
15. Tenhunen O., Soini Y., Ilves M., Rysä J., Tuukkanen J., Serpi R., Pennanen H., Ruskoaho H., and Leskinen H. p38 kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms. FASEB J. 20 (2006) 1907-1909
16. Magga J., Vuolteenaho O., Tokola H., Marttila M., and Ruskoaho H. Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression. Circ. Res. 81 (1997) 694-702
17. Majalahti-Palviainen T., Hirvinen M., Tervonen V., Ilves M., Ruskoaho H., and Vuolteenaho O. Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology 141 (2000) 731-740
18. Sodersten F., Ekman S., Schmitz M., Paulsson M., and Zaucke F. Thrombospondin-4 and cartilage oligomeric matrix protein form heterooligomers in equine tendon. Connect. Tissue Res. 47 (2006) 85-91
19. Sadoshima J., and Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59 (1997) 551-571
20. Gabrielsen A., Lawler P.R., Yongzhong W., Steinbruchel D., Blagoja D., Paulsson-Berne G., Kastrup J., and Hansson G.K. Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. J. Mol. Cell. Cardiol. 42 (2007) 870-883
21. Tan F.L., Moravec C.S., Li J., Apperson-Hansen C., McCarthy P.M., Young J.B., and Bond M. The gene expression fingerprint of human heart failure. Proc. Natl. Acad. Sci. USA 99 (2002) 11387-11392
22. Chapman D., Weber K.T., and Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ. Res. 67 (1990) 787-794
23. Crawford D.C., Chobanian A.V., and Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ. Res. 74 (1994) 727-739
24. Villarreal F.J., and Dillmann W.H. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am. J. Physiol. 262 (1992) H1861-H1866
25. Stenina O.I., Desai S.Y., Krukovets I., Kight K., Janigro D., Topol E.J., and Plow E.F. Thrombospondin-4 and its variants: expression and differential effects on endothelial cells. Circulation 108 (2003) 1514-1519
26. Zhao X.M., Hu Y., Miller G.G., Mitchell R.N., and Libby P. Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts. Circulation 103 (2001) 525-531
27. Tucker R.P., Adams J.C., and Lawler J. Thrombospondin-4 is expressed by early osteogenic tissues in the chick embryo. Dev. Dyn. 203 (1995) 477-490
28. Safar M., Chamiot-Clerc P., Dagher G., and Renaud J.F. Pulse pressure, endothelium function, and arterial stiffness in spontaneously hypertensive rats. Hypertension 38 (2001) 1416-1421
29. Kung C.F., and Luscher T.F. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 25 (1995) 194-200
30. Chatila K., Ren G., Xia Y., Huebener P., Bujak M., and Frangogiannis N.G. The role of the thrombospondins in healing myocardial infarcts. Cardiovasc. Hematol. Agents Med. Chem. 5 (2007) 21-27
31. Bhattacharyya S., Marinic T.E., Krukovets I., Hoppe G., and Stenina O.I. Cell type-specific post-transcriptional regulation of production of the potent antiangiogenic and proatherogenic protein thrombospondin-1 by high glucose. J. Biol. Chem. 283 (2008) 5699-5707